Guy Young Selected Research

Infections

10/2022	Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium.
1/2022	A New Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in Critically Ill Children: A Report From the Children's Hospital-Acquired Thrombosis Consortium.
1/2018	A multi-institutional registry of pediatric hospital-acquired thrombosis cases: The Children's Hospital-Acquired Thrombosis (CHAT) project.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy Young Research Topics

Disease

64	Hemophilia A (Haemophilia) 03/2024 - 02/2005
50	Hemorrhage 03/2024 - 02/2005
20	Venous Thromboembolism 12/2023 - 02/2011
12	Thrombosis (Thrombus) 12/2023 - 01/2004
9	Hemophilia B (Haemophilia B) 01/2023 - 12/2014
5	Thrombotic Microangiopathies 12/2023 - 01/2017
5	Thrombophilia 01/2021 - 04/2010
4	Metrorrhagia (Spotting) 01/2023 - 01/2017
4	Congenital Heart Defects (Congenital Heart Defect) 01/2022 - 04/2011
4	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020 - 10/2011
3	Joint Diseases (Joint Disease) 01/2024 - 02/2005
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 07/2006
3	Body Weight (Weight, Body) 01/2023 - 01/2011
3	Hypersensitivity (Allergy) 01/2023 - 11/2021
3	Infections 10/2022 - 01/2018
3	Thromboembolism 01/2022 - 12/2008
2	Injection Site Reaction 12/2023 - 01/2017
2	Neoplasms (Cancer) 01/2021 - 01/2018
2	Obesity 01/2018 - 01/2012
2	Thrombocytopenia (Thrombopenia) 12/2011 - 12/2008
1	Inflammation (Inflammations) 10/2022
1	Pain (Aches) 07/2022
1	Embolic Stroke 01/2022
1	Embolism (Embolus) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Myocardial Infarction 01/2021
1	Hematuria 11/2020
1	Proteinuria 11/2020
1	Leukopenia 11/2020
1	Lupus Nephritis 11/2020
1	Leukemia 01/2020
1	Sepsis (Septicemia) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Epistaxis (Nosebleed) 09/2014
1	Congenital Diaphragmatic Hernias 09/2013

Drug/Important Bio-Agent (IBA)

27	emicizumabIBA 01/2024 - 01/2017
23	Factor VIII (Coagulation Factor VIII)IBA 01/2024 - 09/2012
11	AnticoagulantsIBA 06/2023 - 09/2007
9	AntibodiesIBA 12/2023 - 10/2011
9	recombinant FVIIa (rFVIIa)FDA Link 07/2023 - 09/2007
8	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2023 - 12/2014
8	Monoclonal AntibodiesIBA 01/2023 - 01/2019
7	Blood Coagulation Factors (Coagulation Factor)IBA 03/2024 - 07/2011
7	AntithrombinsIBA 03/2024 - 01/2004
7	RivaroxabanIBA 06/2023 - 01/2018
7	Prothrombin (Factor II)IBA 01/2023 - 01/2004
6	Thrombin FDA Link 05/2023 - 01/2004
6	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 03/2007
5	Proteins (Proteins, Gene)FDA Link 08/2023 - 07/2016
5	Neutralizing AntibodiesIBA 01/2023 - 01/2006
5	Fondaparinux (Arixtra)FDA Link 01/2020 - 09/2007
4	Hemostatics (Antihemorrhagics)IBA 11/2023 - 08/2009
4	Factor VIIa (Activated Factor VII)IBA 07/2023 - 06/2008
4	nonacog beta pegolIBA 10/2020 - 12/2014
3	fitusiranIBA 03/2024 - 01/2023
3	Factor VII (Proconvertin)IBA 07/2022 - 09/2017
3	Factor IXa (Coagulation Factor IXa)IBA 03/2021 - 01/2017
3	bivalirudin (Angiomax)FDA Link 04/2011 - 09/2007
2	Small Interfering RNA (siRNA)IBA 03/2024 - 01/2023
2	recombinant factor VIII N8IBA 11/2023 - 01/2023
2	concizumabIBA 01/2022 - 11/2019
2	SteroidsIBA 01/2021 - 01/2018
2	factor VIII-Fc fusion proteinIBA 05/2020 - 01/2016
2	Vitamin K FDA Link 01/2020 - 10/2019
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2019 - 12/2008
2	Antiphospholipid AntibodiesIBA 10/2011 - 04/2010
2	ORALIT (ORS)IBA 10/2011 - 04/2010
2	argatroban (MPQA)FDA Link 01/2011 - 09/2007
2	Thromboplastin (Tissue Factor)IBA 06/2008 - 01/2004
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	simoctocog alfa (Nuwiq)IBA 01/2024
1	TESIBA 12/2023
1	Dabigatran FDA Link 06/2023
1	anti-inhibitor coagulant complexIBA 01/2023
1	BESIBA 07/2022
1	BAX 335IBA 11/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	SuspensionsIBA 01/2020
1	TabletsIBA 01/2020
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 11/2019
1	Heme (Haem)IBA 01/2019
1	Factor VIIIaIBA 01/2017
1	Factor X (Stuart Factor)IBA 01/2017
1	Protein CIBA 10/2016
1	Protein SIBA 10/2016
1	von Willebrand FactorIBA 05/2016
1	IsoantibodiesIBA 05/2016
1	Antithrombin IIIIBA 09/2013
1	recombinant human thrombinIBA 04/2013

Therapy/Procedure

29	Therapeutics 06/2023 - 02/2005
14	Central Venous Catheters 12/2023 - 11/2013
9	Catheters 01/2023 - 05/2006
2	Perioperative Care 07/2023 - 11/2021
1	Aftercare (After-Treatment) 01/2023
1	Length of Stay 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2019
1	Self Administration (Administration, Self) 09/2017
1	Tracheostomy 09/2014
1	Extracorporeal Membrane Oxygenation 09/2013